Reagent shortage at BRILS labs for carbamazepine

Date: 02 September 2022

Critical reagent shortage  Carbamazepine

Our reagent suppliers have informed us that there is a critical national shortage of reagents for our carbamazepine assay. We are making contingency plans to allow us to continue to provide this test, likely involving sending requests to a third-party laboratory. However, this is likely to have some impact on current turn-around times for this assay. Consequently, can we please ask that, in the interim, requests for this drug are only sent when clinically indicated (most notably when there is a suspicion of toxicity or non-adherence), and not for routine monitoring purposes. Current estimates from our reagent manufacturer is that stock may be restored in early November.

If you would like further information or wish to discuss this assay or anything else, please do not hesitate to contact Dr Iain Woodrow iain.woodrow@nhs.net 01226 435749 or the laboratory at Barnsley or Rotherham

  • Summary:
  • Clinical support by body system:
  • Newsletter:
  • Audience:
  • Bypass detail page:
  • Bypass detail page and:
  • Clinical Support Group: